Lybrate

Gurugram, India Founded: 2014 • Age: 12 yrs Acquired By Pristyn Care
Online telemedicine platform for doctor consultations and bookings is operated.

About Lybrate

Lybrate is a Healthcare company based in Gurugram (India) founded in 2014, and was acquired by Pristyn Care in June 2022. Online telemedicine platform for doctor consultations and bookings is operated. Lybrate has raised $14.43 million across 3 funding rounds from investors including Pristyn Care, Nexus Venture Partners and Tiger Global. The company has 116 employees. Its website lybrate.com draws about 4.8 million monthly visits. Its Indian entity Lybrate India Private Limited reported revenue of β‚Ή11 Lakh. Lybrate offers products and services including Lybrate App and Online Consultation Service. Its focus areas include HealthTech, Healthcare Booking Platforms, Doctors and Telemedicine. Its competitors include Kivi Health, Qikwell and Clinikk; 3 of its 3 listed competitors have raised funding.

Company details

Lybrate was founded in 2014 in Gurugram, India, within the healthtech sector. An online multi-specialty telemedicine platform is provided, enabling patients to consult doctors through chat, phone, or video. Doctors are searched based on specialization, ratings, and reviews, with appointments booked for virtual or in-person visits. A marketplace for diagnostic tests is offered, alongside a practice management solution for doctors to handle their operations.

  • Headquarters Gurugram, India
  • Employees 116
  • Stage Acquired
  • Sectors
    Healthcare
  • Website category Health
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website lybrate.com
  • Social LinkedIn X Facebook
  • Acquired by Pristyn Care (Jun 2022)
  • Legal Name Lybrate India Private Limited
  • Date of Incorporation 25 Jul, 2014
  • Jurisdiction Faridabad, Haryana, India
Key Metrics
  • Annual Revenue
    ₹11 Lakh

    FY 2025 · -89% YoY

  • Net Loss
    -₹46 Lakh

    FY 2025 · -420% margin

  • EBITDA
    -₹46 Lakh

    FY 2025 · -420% margin

  • Total Equity Funding
    $14.43M (USD)

    in 3 rounds

  • Latest Funding Round
    $3M (USD), Series A

    Apr 2017

  • Investors
  • Employee Count
    116
  • Acquired by
    Pristyn Care

    (Jun 2022)

Products & Services of Lybrate

Lybrate offers a comprehensive portfolio of products and services, including Lybrate App and Online Consultation Service.

Lybrate App
Telemedicine Platform

App for online doctor consultations and appointments.

Online Consultation Service
Health Advisory

Service for virtual doctor interactions and health queries.

Funding Insights of Lybrate

Lybrate has successfully raised a total of $14.43M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in April 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $14.43M
  • Total Rounds 3
  • Last Round Series A β€” $3M
  • First Round $1.23M

    (Aug 2014)

  • Investors Count 3

All 3 funding rounds of Lybrate with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2017$3MSeries A––
–
Jul 2015$10.2MSeries A–Tiger Global Management
Aug 2014$1.23MSeed–Nexus Venture Partners
–
Valuation history

4 investors in total: 3 institutional and 1 angel.

Investors in Lybrate

Lybrate has secured backing from 4 investors, including venture fund and angel investors. Prominent investors backing the company include Pristyn Care, Nexus Venture Partners and Tiger Global.

All
Venture Fund
Angel
InvestorDescriptionFounded YearDomainLocation
Venture and private equity investments are managed with global diversification.
tigerglobal.comNew York, United States
Venture capital firm that partners with entrepreneurs for product-first companies.
2006nexusvp.comMenlo Park, United States

Ratan N Tata

Chairman Emeritus of Tata Sons, iconic industrialist, and active angel investor
unknown_e7a65f9d622344b69
Online platform for booking medical appointments and consultations is provided.
2018pristyncare.comGurugram, India
Premium access

Investor details for Lybrate

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Lybrate India Private Limited (Lybrate)

Lybrate India Private Limited is the primary company behind Lybrate. The board of Lybrate India Private Limited currently have 2 directors; the longest-serving is Chaman Lal Pardesi, appointed in 2014.

DirectorDesignationAppointedTenureEntity
Chaman Lal Pardesi
DIN 06666100
Director25 Jul 201412 yrs 3 moLybrate India Private Limited
Saurabh Arora
DIN 06906792
Director25 Jul 201412 yrs 3 moLybrate India Private Limited

People of Lybrate

9 people are tracked at Lybrate (1 in leadership, 8 in team); the tracked headcount is 116.

NameRoleGroup
Ram Niwas Vishwakarma
Head-Key Account Management & RenewalsLeadership
Shivansh Jain
Digital Sales ManagerTeam
Chetna Bhatia
Business Development - Inside Sales SpecialistTeam
Manisha Gera
Operation AnalystTeam
neeraj chandel
operation analystTeam
Sneha Aish
Inside Sales SpecialistTeam
Thomas Bernard
Senior Account AnalystTeam
Kailash Singh
Sales Team LeadTeam
Anuradha Giri
Operations AnalystTeam
Premium access

Complete people profiles for Lybrate

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Lybrate

Figures of Lybrate India Private Limited, the primary company behind Lybrate, for FY 2025. Revenue was ₹11 Lakh (-89% year on year). Net loss was -₹46 Lakh (-420% margin). EBITDA was -₹46 Lakh (-420% margin). Revenue has grown at a compounded annual rate of -85% over three years and -69% over five years.

  • ₹11 LakhRevenue · FY 2025 · -89% YoY
  • -₹46 LakhNet loss · -420% margin
  • -₹46 LakhEBITDA · -420% margin
  • ₹1.10 CrPaid-up capital
  • 116Employees (provident fund records)
  • -85%Revenue CAGR, 3 years
  • -69%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Lybrate India Private Limited are on its company page.

Premium access

Detailed financial statements for Lybrate

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Lybrate

4 dated milestones of Lybrate across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Lybrate is founded.
  2. Funding First funding round of $1.2M.
  3. Funding Latest funding round, Series A, of $3.0M.
  4. Exit Acquired by Pristyn Care.

Competitors of Lybrate

Lybrate has 3 listed competitors in our database, 3 of them funded. They include Kivi Health, Qikwell and Clinikk.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
kivihealth.com2015Ahmedabad, India$712,471175
Healthcare marketplace for appointment booking
qikwell.com2011Bengaluru, India$3.21M108
Online doctor appointment booking platform
clinikk.com2016Bengaluru, India$9.83M86
Primary healthcare services are offered via annual membership plans.
Premium access

Detailed competitors of Lybrate

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Lybrate

The website of Lybrate (lybrate.com) receives about 4.8M visits a month and ranks #14,716 among all websites worldwide, #293 in Health.

  • Monthly visits
    4.8M

    ▼ 4.3% vs previous month

  • Unique visitors
    3.4M

    per month

  • Global rank
    #14,716

    among all websites

  • Category rank
    #293

    Health · Health

Similar websites

Websites whose visitors overlap most with Lybrate. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
practo.com
100%
12M#4,689View details
myupchar.com
88%
3.5M#17,980View details
hexahealth.com
83%
1.5M#42,028View details
pristyncare.com
82%
2M#40,826View details
maxhealthcare.in
78%
1.5M#37,801View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Lybrate

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Digital Health & Telemedicine

3 companies that operate in the same segment as Lybrate (Digital Health & Telemedicine) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of an online pharmacy with doctor listing and teleconsultation services
2015Delhi, Delhi, IndiaUSD 230.8 MUSD 328.97 M5,212
Online platform offering multiple healthcare services
2013Bengaluru, Karnataka, IndiaUSD 199.22 MUSD 62.4 M52
An online marketplace for healthcare products is operated.
2011Kolkata, West Bengal, IndiaUSD 38.26 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Lybrate

Premium access

Complete news archive for Lybrate

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Articles about Lybrate on our blog

Frequently Asked Questions about Lybrate

Lybrate was founded in 2014.

Lybrate is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.

Lybrate is a funded company, having raised a total of $14.43M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.23M, raised on Aug 2014.

Lybrate has 116 employees.

The primary company behind Lybrate, Lybrate India Private Limited, reported revenue of β‚Ή11 Lakh for FY 2025, down 89% year on year.

Lybrate was founded in 2014 in Gurugram, India, within the healthtech sector. An online multi-specialty telemedicine platform is provided, enabling patients to consult doctors through chat, phone, or video. Doctors are searched based on specialization, ratings, and reviews, with appointments booked for virtual or in-person visits. A marketplace for diagnostic tests is offered, alongside a practice management solution for doctors to handle their operations.

Lybrate's top competitors include Clinikk, Qikwell and Kivi Health.

Lybrate offers Lybrate App and Online Consultation Service.

Lybrate has 4 investors. Key investors include Pristyn Care, Nexus Venture Partners, Tiger Global, and Ratan N Tata.

Lybrate operates through Lybrate India Private Limited.

Yes. Lybrate was acquired by Pristyn Care in June 2022.

The legal entities of Lybrate currently have 2 directors, including Chaman Lal Pardesi, Saurabh Arora.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available